Contrasting Ramsay Health Care (OTCMKTS:RMYHY) & Progyny (NASDAQ:PGNY)

Ramsay Health Care (OTCMKTS:RMYHYGet Free Report) and Progyny (NASDAQ:PGNYGet Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Valuation & Earnings

This table compares Ramsay Health Care and Progyny”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ramsay Health Care N/A N/A N/A N/A N/A
Progyny $1.17 billion 1.50 $54.34 million $0.63 32.32

Progyny has higher revenue and earnings than Ramsay Health Care.

Profitability

This table compares Ramsay Health Care and Progyny’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ramsay Health Care N/A N/A N/A
Progyny 4.46% 10.71% 7.27%

Risk & Volatility

Ramsay Health Care has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Comparatively, Progyny has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Ramsay Health Care and Progyny, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ramsay Health Care 1 2 0 0 1.67
Progyny 0 4 8 0 2.67

Progyny has a consensus price target of $29.80, indicating a potential upside of 46.37%. Given Progyny’s stronger consensus rating and higher possible upside, analysts plainly believe Progyny is more favorable than Ramsay Health Care.

Institutional and Insider Ownership

94.9% of Progyny shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Progyny beats Ramsay Health Care on 10 of the 10 factors compared between the two stocks.

About Ramsay Health Care

(Get Free Report)

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

About Progyny

(Get Free Report)

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Receive News & Ratings for Ramsay Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ramsay Health Care and related companies with MarketBeat.com's FREE daily email newsletter.